立即開始
ReutersReuters

Mayne Pharma Signs Transaction Agreement & Related License Agreement With TherapeuticsMD

MYX

Mayne Pharma Group Ltd MYX:

  • SIGNED TRANSACTION AGREEMENT AND RELATED LICENSE AGREEMENT WITH THERAPEUTICSMD

  • COMPLETION IS EXPECTED BY END OF CALENDAR YEAR 2022 PENDING SATISFACTION OF CUSTOMARY CLOSING CONDITIONS

  • DEAL FOR US$140 MILLION

  • DEAL IMMEDIATELY ADDITIVE TO NET PROFIT AFTER TAX

登入或建立一個永久免費帳戶來閱讀此新聞